ATARA BIOTHERAPEUTICS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $233.1M | $62.4M |
| Jun 2017 | — | $221.1M | $64.2M |
| Sep 2017 | — | $206.0M | $60.5M |
| Dec 2017 | — | $177.9M | $79.2M |
| Mar 2018 | — | $439.2M | $90.5M |
| Jun 2018 | — | $452.5M | $103.2M |
| Sep 2018 | — | $403.1M | $66.0M |
| Dec 2018 | — | $339.2M | $60.7M |
| Mar 2019 | — | $283.9M | $56.2M |
| Jun 2019 | — | $232.3M | $59.2M |
| Sep 2019 | — | $318.4M | $94.4M |
| Dec 2019 | — | $290.8M | $74.3M |
| Mar 2020 | — | $252.8M | $70.2M |
| Jun 2020 | — | $381.1M | $74.5M |
| Sep 2020 | — | $353.9M | $62.6M |
| Dec 2020 | — | $462.3M | $200.4M |
| Mar 2021 | — | $399.0M | $151.1M |
| Jun 2021 | — | $331.5M | $123.9M |
| Sep 2021 | — | $310.1M | $113.2M |
| Dec 2021 | — | $279.6M | $106.1M |
| Mar 2022 | — | $224.3M | $101.7M |
| Jun 2022 | — | $257.5M | $70.7M |
| Sep 2022 | — | $187.1M | $65.1M |
| Dec 2022 | — | $126.6M | $92.9M |
| Mar 2023 | — | $65.0M | $48.7M |
| Jun 2023 | — | $7.5M | $45.9M |
| Sep 2023 | — | $-50.8M | $64.8M |
| Dec 2023 | — | $99.2M | $25.8M |
| Mar 2024 | — | $-98.3M | $35.1M |
| Jun 2024 | — | $-110.9M | $31.3M |
| Sep 2024 | — | $-90.5M | $46.5M |
| Dec 2024 | — | $-97.3M | $25.0M |
| Mar 2025 | — | $-55.1M | $13.8M |
| Jun 2025 | — | $-35.0M | $16.9M |
| Sep 2025 | — | $-36.6M | $5.7M |
| Dec 2025 | — | $-38.5M | $8.5M |
| Mar 2026 | — | $-37.3M | $8.4M |
| Jun 2026 | — | $-37.0M | $3.2M |